Cancers,
Год журнала:
2024,
Номер
17(1), С. 74 - 74
Опубликована: Дек. 29, 2024
Magnetic
resonance
imaging
(MRI)
currently
serves
as
the
primary
diagnostic
method
for
glioma
detection
and
monitoring.
The
integration
of
neurosurgery,
radiation
therapy,
pathology,
radiology
in
a
multi-disciplinary
approach
has
significantly
advanced
its
diagnosis
treatment.
However,
prognosis
remains
unfavorable
due
to
treatment
resistance,
inconsistent
response
rates,
high
recurrence
rates
after
surgery.
These
factors
are
closely
associated
with
complex
molecular
characteristics
tumors,
internal
heterogeneity,
relevant
external
microenvironment.
complete
removal
gliomas
presents
challenges
their
infiltrative
growth
pattern
along
white
matter
fibers
perivascular
space.
Therefore,
it
is
crucial
comprehensively
understand
features
analyze
tumor
heterogeneity
order
accurately
characterize
quantify
invasion
range.
multi-parameter
quantitative
MRI
technique
provides
an
opportunity
investigate
microenvironment
aggressiveness
tumors
at
cellular,
blood
perfusion,
cerebrovascular
levels.
this
review
examines
current
applications
research
explores
prospects
future
development.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(9), С. 2712 - 2712
Опубликована: Май 5, 2024
The
transorbital
approach
(TOA)
is
gaining
popularity
in
skull
base
surgery
scenarios.
This
represents
a
valuable
surgical
corridor
to
access
various
compartments
and
safely
address
several
intracranial
pathologies,
both
intradurally
extradurally,
including
tumors
of
the
olfactory
groove
anterior
cranial
fossa
(ACF),
cavernous
sinus
middle
(MCF),
cerebellopontine
angle
posterior
(PCF).
TOA
exists
many
variants,
from
point
view
invasiveness
that
entry
orbit,
corresponding
four
orbital
quadrants:
superior
eyelid
crease
(SLC),
precaruncular
(PC),
lateral
retrocanthal
(LRC),
preseptal
lower
(PS).
Moreover,
multiportal
consisting
combination
with
others,
exist
are
relevant
reach
peculiar
territories.
significance
neurosurgery,
coupled
dearth
thorough
studies
assessing
its
applications
adaptations,
underscores
necessity
for
this
research.
extensive
review
delineates
multitude
target
lesions
reachable
through
route,
categorizing
them
based
on
complexity.
Furthermore,
it
provides
an
overview
different
variations,
standalone
conjunction
other
techniques.
By
offering
comprehensive
understanding,
study
aims
enhance
awareness
knowledge
regarding
current
utility
neurosurgery.
Additionally,
steer
future
investigations
toward
deeper
exploration,
refinement,
exploration
additional
perspectives
concerning
method.
Medicina,
Год журнала:
2024,
Номер
60(7), С. 1115 - 1115
Опубликована: Июль 9, 2024
Although
lumbar
synovial
cysts
(LSCs)
are
frequently
described
in
the
literature,
they
a
relatively
uncommon
cause
of
low
back
and
radicular
leg
pain.
Furthermore,
their
spontaneous
resolution
is
an
even
rarer
event.
The
standard
treatment
cyst
surgical
excision.
Spontaneous
literature
sporadic
In
our
experience,
we
have
had
two
cases
where
disappeared
spontaneously.
To
date,
only
nine
been
documented
literature.
this
discussion,
highlight
pathology
that
typically
suggests
intervention,
yet
conservative
can
be
viable
alternative.
We
present
large
were
initially
scheduled
for
surgery
but
ultimately
resolved
spontaneously
without
any
treatment.
While
extremely
rare,
strategies
option
should
not
overlooked.
Our
contribute
to
growing
body
evidence
on
regression
symptomatic
LSC,
potentially
enhancing
understanding
disease's
natural
progression
future.
Cancers,
Год журнала:
2025,
Номер
17(5), С. 879 - 879
Опубликована: Март 4, 2025
Malignant
glioma
is
a
highly
aggressive,
therapeutically
non-responsive,
and
deadly
disease
with
unique
tumor
microenvironment
(TME).
Of
the
14
currently
recognized
described
cancer
hallmarks,
five
are
especially
implicated
in
malignant
targetable
repurposed
drugs:
stem-like
cells,
general,
cells
particular
(GSCs),
vascularization
hypoxia,
metabolic
reprogramming,
tumor-promoting
inflammation
sustained
proliferative
signaling.
Each
hallmark
drives
development,
both
individually
through
interactions
other
which
TME
plays
critical
role.
To
combat
aggressive
spatio-temporal
heterogeneity
driven
by
interactions,
to
overcome
its
therapeutic
challenges,
combined
treatment
strategy
including
anticancer
therapies,
drugs
multimodal
immunotherapy
should
be
aim
for
future
approaches.
Applied Sciences,
Год журнала:
2025,
Номер
15(7), С. 3791 - 3791
Опубликована: Март 30, 2025
Brain
tumors
are
a
type
of
disease
that
affects
people’s
health
and
have
received
extensive
attention.
Accurate
segmentation
Magnetic
Resonance
Imaging
(MRI)
images
for
brain
is
essential
effective
treatment
strategies.
However,
there
scope
enhancing
the
accuracy
established
deep
learning
approaches,
such
as
3D
U-Net.
In
pursuit
improved
precision
tumor
MRI
images,
we
propose
MEASegNet,
which
incorporates
multiple
efficient
attention
mechanisms
into
U-Net
architecture.
The
encoder
employs
Parallel
Channel
Spatial
Attention
Block
(PCSAB),
bottleneck
layer
leverages
Reduce
Residual
Atrous
Pyramid
Pooling
(CRRASPP)
attention,
decoder
Selective
Large
Receptive
Field
(SLRFB).
Through
integration
various
mechanisms,
enhance
capacity
detailed
feature
extraction,
facilitate
interplay
among
distinct
features,
ensure
retention
more
comprehensive
information.
Consequently,
this
leads
to
an
enhancement
in
images.
conclusion,
our
experimentation
on
BraTS2021
dataset
yields
Dice
scores
92.50%,
87.49%,
84.16%
Whole
Tumor
(WT),
Core
(TC),
Enhancing
(ET),
respectively.
These
results
indicate
marked
improvement
over
conventional
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(7), С. 2518 - 2518
Опубликована: Апрель 7, 2025
Background/Objectives:
Glioblastoma
ranks
among
the
most
aggressive
brain
tumors,
with
poor
prognosis.
Currently,
there
are
insufficient
data
regarding
prognostic
value
of
isocitrate
dehydrogenase
(IDH)
mutation
status
and
inflammatory
markers.
This
study
demonstrates
IDH
preoperative
markers
in
glioblastoma.
Methods:
single-center
retrospective
encompassed
66
glioblastoma
patients
who
had
surgical
treatment
our
institution
from
January
2020
to
March
2022.
The
were
categorized
into
two
groups:
IDH-mutant
(n
=
30)
IDH-wild-type
36).
We
made
a
comparative
assessment
demographic
characteristics,
clinical
parameters,
blood
survival
outcome
across
groups.
Statistical
analyses
included
Kaplan-Meier
curves,
ROC
analysis,
multivariate
Cox
regression.
Results:
group
demonstrated
significantly
lower
mean
age
(53.93
±
12.00)
compared
wild-type
(62.39
10.12)
(p
0.003).
Median
overall
was
notably
longer
group,
at
16.0
months,
versus
6.5
months
0.030).
An
elevated
neutrophil/lymphocyte
ratio
above
3.39
(sensitivity
95.12%,
specificity
52.0%)
platelet/lymphocyte
exceeding
136.25
80.49%,
64.0%)
associated
regression
analysis
identified
(HR
2.84,
95%
CI:
1.56-5.18)
NLR
1.84,
1.16-2.92)
as
independent
factors.
Conclusions:
show
that
glioblastomal
have
poorer
In
this
case,
metrics
seem
be
supplied
some
biomarkers
for
expansion
disease
predicting
likely
outcomes.
Biomedicines,
Год журнала:
2024,
Номер
12(6), С. 1376 - 1376
Опубликована: Июнь 20, 2024
Glioblastoma
multiforme
(GBM)
is
one
of
the
most
aggressive
forms
brain
tumor,
characterized
by
a
daunting
prognosis
with
life
expectancy
hovering
around
12–16
months.
Despite
century
relentless
research,
only
select
few
drugs
have
received
approval
for
tumor
treatment,
largely
due
to
formidable
barrier
posed
blood–brain
barrier.
The
current
standard
care
involves
multifaceted
approach
combining
surgery,
irradiation,
and
chemotherapy.
However,
recurrence
often
occurs
within
months
despite
these
interventions.
challenges
drug
delivery
overcoming
therapeutic
resistance
become
focal
points
in
treatment
tumors
are
deemed
essential
recurrence.
In
recent
years,
promising
wave
advanced
treatments
has
emerged,
offering
glimpse
hope
overcome
limitations
existing
therapies.
This
review
aims
highlight
cutting-edge
technologies
ongoing
stages
development,
providing
patients
valuable
insights
guide
their
choices
treatment.
Biomedicines,
Год журнала:
2024,
Номер
12(10), С. 2237 - 2237
Опубликована: Окт. 1, 2024
:
Despite
current
treatments
extending
the
lifespan
of
Glioblastoma
(GBM)
patients,
average
survival
time
is
around
15-18
months,
underscoring
fatality
GBM.
This
study
aims
to
investigate
impact
sample
heterogeneity
on
gene
expression
in
GBM,
identify
key
metabolic
pathways
and
modules,
explore
potential
therapeutic
targets.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(20), С. 10965 - 10965
Опубликована: Окт. 11, 2024
Glioblastoma
(GBM)
is
a
highly
malignant
and
devastating
brain
cancer
characterized
by
its
ability
to
rapidly
aggressively
grow,
infiltrating
tissue,
with
nearly
universal
recurrence
after
the
standard
of
care
(SOC),
which
comprises
maximal
safe
resection
followed
chemoirradiation
(CRT).
The
metabolic
triggers
leading
reprogramming
tumor
behavior
resistance
are
an
area
increasingly
studied
in
relation
molecular
features
associated
outcome.
There
currently
no
metabolomic
biomarkers
for
GBM.
Studying
alterations
GBM
patients
undergoing
CRT
could
uncover
biochemical
pathways
involved
response
resistance,
identification
novel
optimization
treatment
response.
feature
selection
process
identifies
key
factors
improve
model’s
accuracy
interpretability.
This
study
utilizes
combined
approach,
incorporating
both
Least
Absolute
Shrinkage
Selection
Operator
(LASSO)
Minimum
Redundancy–Maximum
Relevance
(mRMR),
alongside
rank-based
weighting
method
(i.e.,
MetaWise)
link
12-month
20-month
overall
survival
(OS)
status
Our
shows
promising
results,
reducing
dimensionality
when
employed
on
serum-based
large-scale
datasets
(University
Florida)
all
our
analyses.
proposed
successfully
identified
set
eleven
serum
shared
among
three
datasets.
computational
results
show
that
utilized
achieves
96.711%,
92.093%,
86.910%
rates
48,
46,
33
selected
CRT,
12-month,
OS-based
datasets,
respectively.
discovery
has
implications
developing
personalized
plans
improving
patient
outcomes.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(23), С. 13004 - 13004
Опубликована: Дек. 3, 2024
Gliomas
are
a
heterogeneous
group
of
brain
tumors,
among
which
the
most
aggressive
subtype
is
glioblastoma,
accounting
for
60%
cases
in
adults.
Available
systemic
treatment
options
few
and
ineffective,
so
new
approaches
to
therapies
glioblastoma
high
demand.
In
total,
131
patients
with
diffuse
glioma
were
studied.
Paired
tumor-normal
samples
sequenced
on
Illumina
platform;
panel
included
812
genes
associated
cancer
development.
Molecular
profiles
clinically
distinct
groups
investigated.
low-grade
(LGG)
(n
=
18),
common
mutations
Medicina,
Год журнала:
2024,
Номер
60(10), С. 1688 - 1688
Опубликована: Окт. 14, 2024
Schimmelpenning
syndrome,
or
epidermal
nevus
is
a
rare,
neurocutaneous
disorder
characterized
by
skin
abnormalities,
such
as
nevi,
and
involvement
of
the
central
nervous
system,
including
intracranial
tumors.
There
are
only
few
reported
cases
tumors
associated
with
syndrome.
In
most
cases,
single
nucleotide
mutation
in
RAS
family
proto-oncogenes,
like